SERPINE2 boosts the in vivo invasiveness of its highly metastatic cancer cells via LRP1-mediated induction of MMP9 (35), and SERPINE2 indirectly enhances the invasive potential of cancer cells in PDA by activating surrounding stromal cells (36). Here, MMP9 is linked to Patent ductus arteriosus.